Durable efficacy of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis who relapsed on a prior therapy - Singer, B; Fox, E J; Krieger, S
Poster presented at: 67th American Academy of Neurology Annual Meeting; April 18–25, 2015; Washington, DC